SCHEMBL30176307

SCHEMBL30176307

COC(=O)Cc1c(C2CC2)n(-c2ccc(F)c(C)c2)c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 7/20 0.45
EDNRB P24530 2/20 0.43
EDNRA P25101 2/20 0.43
HTR3A P46098 1/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
CNR2 P34972 3/20 0.38
CNR1 P21554 2/20 0.38
AKR1C3 P42330 2/20 0.37
PTGS2 P35354 2/20 0.37
S1PR1 P21453 1/20 0.37
S1PR5 Q9H228 1/20 0.37
MCHR1 Q99705 1/20 0.37
LTB4R Q15722 1/20 0.37
LTB4R2 Q9NPC1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23886720 1.00 PLA2G2A (0.45) PLA2G2AEDNRBEDNRAHTR3AMEN1
SCHEMBL28995426 0.88 PLA2G2A (0.46) PLA2G2AEDNRBEDNRALTB4RLTB4R2
SCHEMBL30176288 0.86 EDNRB (0.45) PLA2G2AEDNRBEDNRAMEN1NPC1
SCHEMBL23886955 0.86 EDNRB (0.45) PLA2G2AEDNRBEDNRAMEN1NPC1
SCHEMBL28995402 0.85 EDNRB (0.40) PLA2G2AEDNRBEDNRAHTR3AMEN1
SCHEMBL23886750 0.83 HTR3A (0.42) PLA2G2AEDNRBEDNRAHTR3AMEN1
SCHEMBL30176263 0.83 HTR3A (0.42) PLA2G2AEDNRBEDNRAHTR3AMEN1
SCHEMBL30337916 0.83 HTR3A (0.42) PLA2G2AEDNRBEDNRAHTR3AMEN1
SCHEMBL23886835 0.82 HTR3A (0.42) PLA2G2AEDNRBEDNRAHTR3AMEN1
SCHEMBL30176346 0.82 HTR3A (0.42) PLA2G2AEDNRBEDNRAHTR3AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126817-A1 SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed